Ibex Investors’s Abiomed Inc ABMD Stock Holding History

Ibex Investors’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-733	Closed	-$238K	–	147
2018 Q4	$238K	Buy	+733	New	+$255K	0.04%	62
2018 Q3	–	Sell	-949	Closed	-$388K	–	278
2018 Q2	$388K	Buy	+949	New	+$344K	0.22%	105

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Ibex Investors's ABMD Position: Q1 2019 in Review

Ibex Investors sold out of Abiomed Inc (ABMD) in Q1 2019, closing a stake of 733 shares — an estimated $238K sold.

Ibex Investors first reported a position in ABMD in Q2 2018 and held it in 2 quarters. The position peaked at $388K in Q2 2018. 559 funds tracked by Wall St. Rank hold ABMD as of Q1 2019.

Ibex Investors reported no remaining Abiomed Inc position as of Q1 2019 after selling out during the quarter.
Ibex Investors sold 733 Abiomed Inc shares in Q1 2019, an estimated $238K.
Ibex Investors first reported a position in Abiomed Inc in Q2 2018 and held it in 2 quarters.
Ibex Investors's Abiomed Inc position peaked at $388K in Q2 2018.
559 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2019.

Based on Ibex Investors's 13F filing for Q1 2019, filed 7 May 2019.